MedTrace Logo

Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization

NCT06372665 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15357

Last updated 2025-08-28

No results posted yet for this study

Summary

This is a single-arm, non-randomized, open-label post-marketing safety observation study. The purpose of this study is to investigate the safety of JEV-I given with primary immunization in a large amount of healthy children aged 8 months and older.

Conditions

  • Japanese Encephalitis

Sponsors & Collaborators

  • Liaoning Chengda Biotechnology CO., LTD

    lead INDUSTRY

Principal Investigators

  • Huanyu Wang · Liaoning Chengda Biotechnology CO., LTD

Eligibility

Min Age
8 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06372665 on ClinicalTrials.gov